Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +0.47% | -11.62% | -29.24% |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Business Summary
Number of employees: 94
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Programmable Epigenomic mRNA Medicines
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 22-05-22 |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Ling Zeng
ADM | Chief Administrative Officer | 55 | 22-03-29 |
Thomas McCauley
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-06-30 |
Yan Moore
CTO | Chief Tech/Sci/R&D Officer | 58 | 22-01-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 21-04-30 |
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Mary Szela
BRD | Director/Board Member | 60 | 19-05-31 |
Richard Young
BRD | Director/Board Member | 70 | 17-07-31 |
Michelle Werner
BRD | Director/Board Member | - | 23-08-27 |
Elliott Levy
BRD | Director/Board Member | 64 | 21-02-28 |
Rainer Boehm
BRD | Director/Board Member | 63 | 22-08-31 |
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,154,985 | 50,786,046 ( 92.08 %) | 0 | 92.08 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.24% | 117M | |
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- OMGA Stock
- Company Omega Therapeutics, Inc.